![]() ValenTx ValenTx is an early-stage medical device company developing a non-surgical, implantable medical therapy to treat obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. | AptamiR Therapeutics AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders. | ![]() Cell MedX Cell MedX Corp. is an early development stage company focused on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications. | |
Founding Date | Founding Date 2002 | Founding Date 2012 | Founding Date 2014 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Maple Grove, US HQ | Locations Austin, US HQ | Locations Carson City, US HQ |
Employees | Employees 10 | Employees N/A | Employees 150% decrease |
Funding | |||
Latest funding round | Latest funding round $ 10.3m (almost 8 years ago) | Latest funding round $ 3m (over 10 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 38.1m | Total funding raised $ 3m | Total funding raised N/A |
AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders.
View company
Cell MedX Corp. is an early development stage company focused on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications.
View company